Back to Semaglutide research
semaglutide glp 1 agonist other 2022-10-20 ClinicalTrials

Oral Semaglutide's Real-World Performance in Finnish Type 2 Diabetes Patients Investigated

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice

Abstract

A Multi-centre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Use of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in Finland NCT ID: NCT05443191…

semaglutide glp 1 agonist glp-1r protocol relevant
Source: clinicaltrials:NCT05443191 · Ingested 2026-04-03 · Digest: gemini-2.5-flash